Institution
Robert Koch Institute
Government•Berlin, Germany•
About: Robert Koch Institute is a government organization based out in Berlin, Germany. It is known for research contribution in the topics: Population & Virus. The organization has 3520 authors who have published 7838 publications receiving 324414 citations. The organization is also known as: RKI & Robert Koch-Institut.
Topics: Population, Virus, Public health, Vaccination, Escherichia coli
Papers published on a yearly basis
Papers
More filters
TL;DR: It is demonstrated that SARS-CoV-2 uses the SARS -CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming, and it is shown that the sera from convalescent SARS patients cross-neutralized Sars-2-S-driven entry.
15,362 citations
Ashkan Afshin, Mohammad H. Forouzanfar, Marissa B Reitsma, Patrick J Sur +164 more•Institutions (70)
TL;DR: The rapid increase in the prevalence and disease burden of elevated BMI highlights the need for continued focus on surveillance of BMI and identification, implementation, and evaluation of evidence‐based interventions to address this problem.
Abstract: BACKGROUND Although the rising pandemic of obesity has received major attention in many countries, the effects of this attention on trends and the disease burden of obesity remain uncertain. METHOD ...
4,519 citations
Jeffrey D. Stanaway1, Ashkan Afshin1, Emmanuela Gakidou1, Stephen S Lim1 +1050 more•Institutions (346)
TL;DR: This study estimated levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs) by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017 and explored the relationship between development and risk exposure.
2,910 citations
TL;DR: In this article, the authors used a Bayesian hierarchical model to estimate trends in diabetes prevalence, defined as fasting plasma glucose of 7.0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs in 200 countries and territories in 21 regions, by sex and from 1980 to 2014.
2,782 citations
TL;DR: In this paper , the authors presented the most comprehensive estimates of AMR burden to date, which can be divided into five broad components: number of deaths where infection played a role, proportion of infectious deaths attributable to a given infectious syndrome, proportionof infectious syndrome deaths attributed to a particular pathogen, the percentage of a given pathogen resistant to an antibiotic of interest, and the excess risk of death or duration of an infection associated with this resistance.
2,710 citations
Authors
Showing all 3536 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Bernard Rosner | 190 | 1162 | 147661 |
| Jürgen Rehm | 126 | 1132 | 116037 |
| Lieping Chen | 120 | 421 | 73624 |
| Ulrich Wahn | 100 | 556 | 35746 |
| Bernhard Hube | 82 | 287 | 21580 |
| Margitta Worm | 76 | 605 | 23778 |
| Torsten Zuberbier | 74 | 504 | 22990 |
| Christian Bogdan | 70 | 262 | 24367 |
| Stephan Becker | 69 | 236 | 21325 |
| Marcel A. Müller | 68 | 151 | 32996 |
| Jörg Hacker | 67 | 201 | 15461 |
| Ute Römling | 65 | 180 | 16248 |
| Ulrike Ravens-Sieberer | 64 | 251 | 14826 |
| Paul R. Clapham | 62 | 140 | 18947 |
| Burkhard Ludewig | 62 | 223 | 12520 |